Danaher Q4 2023 revenue to decline low-double digits; core revenue above prior guidance

DANAHER CORP /DE/

2023-FY EPS reported $6.38 revenue$23,890,000,000

Estimated Q4 2023 revenue decline low-double digits YoY (non-GAAP core revenue decline above prior high-teens guidance).
Non-GAAP base business core revenue expected to decline mid-single digits, in line with prior guidance.
President and CEO Rainer M. Blair to present at J.P. Morgan Healthcare Conference on Jan 9, 2024.
Full Q4 and FY 2023 earnings call scheduled for Jan 30, 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

DANAHER CORP /DE/ updated its the fourth quarter of 2023 guidance (reaffirmed).

Period: the fourth quarter of 2023
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

On January 8, 2024, in advance of a public webcast presentation at the J.P. Morgan Healthcare Conference on January 9, 2024 Danaher Corporation issued a press release regarding the Company’s anticipated financial performance for the fourth quarter of 2023

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

DANAHER CORP /DE/ filing history →

Source: SEC EDGAR

accession 0000313616-24-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.